The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
At issue is the TPS program, which permits eligible individuals to live and work in the United States if they cannot return to their home countries because of "extraordinary or temporary conditions."
A New Hampshire Republican. A German Holocaust denier. A suspicious bottle of baby oil. An NPR investigation reveals how the alarming rise of antisemitic conspiracy theories reached a state capitol.